KATHRYN TROUPE: Open Payments
NPI 1639170640 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,186 in 13 payments from 8 companies in 2025. Trend: 2023 $279 · 2024 $1,057 · 2025 $1,186
Food & beverage: $1,186
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $392 |
| Novo Nordisk Inc | 2 | $221 |
| Teva Pharmaceuticals USA, Inc. | 2 | $194 |
| GlaxoSmithKline, LLC. | 1 | $108 |
| Neurocrine BioSciences, Inc. | 1 | $91 |
| Xeris Pharmaceuticals, Inc. | 1 | $83 |
| AERIN MEDICAL INC. | 1 | $54 |
| Inspire Medical Systems, Inc. | 1 | $43 |
Products named: AIRSUPRA, Wegovy, BREZTRI, SHINGRIX, Ozempic, UZEDY, AUSTEDO XR, INGREZZA.
Industry payments across MD — which companies pay providers there.
